IA2 and ZnT8 antibody results delay – update
Further information on the delay in release of IA2 and ZnT8 antibody results is provided below, alongside guidance for their interpretation.
Further information on the delay in release of IA2 and ZnT8 antibody results is provided below, alongside guidance for their interpretation.
Updated course programme
NHSGGC Alcohol and Drugs Health Improvement Team Snapshot – April 2024
CLEANING THE ASEPTIC ROOM AND ISOLATOR USED TO PREPARE GENETICALLY MODIFIED ORGANISM PRODUCTS (GMO) For Password contact Lead Pharmacist Clinical Trials R&I
INTRODUCTION TO GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS WITHIN CLINICAL TRIALS For Password contact Lead Pharmacist Clinical Trials R&I
Tracking and Release of IMPs placed into quarantine post delivery at pharmacy sites For Password contact Lead Pharmacist Clinical Trials R&I
Clinical Trial Information Provided to Site On-Call Pharmacists For Password contact Lead Pharmacist Clinical Trials R&I
Management of controlled drug IMPs within pharmacy sites For Password contact Lead Pharmacist Clinical Trials R&I
Incident reporting for pharmacy clinical trials For Password contact Lead Pharmacist Clinical Trials R&I
Role of pharmacy services in support of trials that are hosted by NHS GG&C: an overview For Password contact Lead Pharmacist Clinical Trials R&I